Stroke in patients with aortic stenosis: The simvastatin and ezetimibe in aortic stenosis study

Stroke

Volumn 45, Issue 7, 2014, Pages 1939-1946

  Greve, Anders M ^a   Dalsgaard, Morten ^a   Bang, Casper N ^a   Egstrup, Kenneth ^b   Ray, Simon ^c   Boman, Kurt ^d   Rossebø, Anne B ^e   Gohlke Baerwolf, Christa ^f   Devereux, Richard B ^g   Køber, Lars ^a   Wachtell, Kristian ^g,h  

^a Rigshospitalet   (Denmark)

^b OUH Svendborg Sygehus   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UMEÅ UNIVERSITY   (Sweden)

^e ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

aortic valve stenosis; cardiac surgical procedures; risk factors; stroke

Indexed keywords

EZETIMIBE PLUS SIMVASTATIN; PLACEBO;

ADULT; AGE; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; BRAIN ISCHEMIA; CHA2DS2 VASC SCORE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCORING SYSTEM; SURGICAL MORTALITY; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE;

AORTIC VALVE STENOSIS; CARDIAC SURGICAL PROCEDURES; RISK FACTORS; STROKE;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; AORTIC VALVE STENOSIS; AZETIDINES; COMORBIDITY; CORONARY ARTERY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; STROKE;

EID: 84903791925     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005296     Document Type: Article

References (34)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon ACJ, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118: e523-e661.
2. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33: 2451-2496.
3. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137: 263-272.
4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341: 142-147. (Pubitemid 29325741)
5. Petty GW, Khandheria BK, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Predictors of cerebrovascular events and death among patients with valvular heart disease: A population-based study. Stroke. 2000;31: 2628-2635.
6. Boon A, Lodder J, Cheriex E, Kessels F. Risk of stroke in a cohort of 815 patients with calcification of the aortic valve with or without stenosis. Stroke. 1996;27: 847-851. (Pubitemid 26142514)
7. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, et al. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol. 2007;99: 970-973. (Pubitemid 46483289)
8. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al SEAS Investigators. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359: 1343-1356.
9. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, et al. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). Am J Cardiol. 2011;108: 541-547.
10. Prineas RJ, Crowe RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Bristol, UK: John Wright; 1982.
11. Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. J Am Coll Cardiol Cardiovasc Imaging. 2009;2: 390-399.
12. Carabello BA. What is new in the 2006 ACC/AHA guidelines on valvular heart disease? Curr Cardiol Rep. 2008;10: 85-90.
13. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al EAE/ASE. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr. 2009;10: 1-25.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57: 450-458. (Pubitemid 16119719)
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18: 1440-1463. (Pubitemid 41821197)
16. Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, et al ACC; AHA; ASE. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr. 2003;16: 1091-1110.
17. Andersen PK, Gill R.D. Cox's regression model for counting processes: A Large Sample Study. Ann Stat. 1982;10: 1100-1120.
18. Andersen PK, Pohar Perme M. Inference for outcome probabilities in multi-state models. Lifetime Data Anal. 2008;14: 405-431.
19. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115: 928-935. (Pubitemid 46294733)
20. Daneault B, Kirtane AJ, Kodali SK, Williams MR, Genereux P, Reiss GR, et al. Stroke associated with surgical and transcatheter treatment of aortic stenosis: A comprehensive review. J Am Coll Cardiol. 2011;58: 2143-2150.
21. Higgins J, Ye J, Humphries KH, Cheung A, Wood DA, Webb JG, et al. Early clinical outcomes after transapical aortic valve implantation: A propensity-matched comparison with conventional aortic valve replacement. J Thorac Cardiovasc Surg. 2011;142: e47-e52.
22. Eggebrecht H, Schmermund A, Voigtländer T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-analysis of 10,037 published patients. EuroIntervention. 2012;8: 129-138.
23. Barbash IM, Waksman R. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the Edwards SAPIEN™ transcatheter heart valve. Circulation. 2012;125: 550-555.
24. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: A prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol. 2010;55: 1427-1432.
25. Gulbins H, Florath I, Ennker J. Cerebrovascular events after stentless aortic valve replacement during a 9-year follow-up period. Ann Thorac Surg. 2008;86: 769-773.
26. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36: 1152-1158.
27. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, et al. Aortic valve replacement: A prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009;54: 1862-1868.
28. Healey J. Global variations in the 1-year rates of death and stroke in 15,432 patients presenting to the emergeny department with atrial fibrillation in 47 countries: The RE-LY AF Registry. European Society of Cardiology 2012 Congress; August 29, 2012; Munich, Germany. 2012.
29. Ntaios G, Lip GY, Makaritsis K, Papavasileiou V, Vemmou A, Koroboki E, et al. CHADS2, CHA2S2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation. Neurology. 2013;80: 1009-1017.
30. Turpie AG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993;329: 524-529. (Pubitemid 23232620)
31. ElBardissi AW, DiBardino DJ, Chen FY, Yamashita MH, Cohn LH. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? J Thorac Cardiovasc Surg. 2010;139: 1137-1145.
32. Mérie C, Køber L, Olsen PS, Andersson C, Jensen JS, Torp-Pedersen C. Risk of stroke after coronary artery bypass grafting: effect of age and comorbidities. Stroke. 2012;43: 38-43.
33. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with nonrheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46: 9-14. (Pubitemid 40905122)
34. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150: 288-293. (Pubitemid 41116255)